Muscle SOCS3 is therefore positioned to play an important role in the pathogenesis of obesity-induced insulin resistance and type 2 diabetes by antagonizing both leptin and insulin signaling in skeletal muscle. This evidence concerns the gene INS and type 2 diabetes mellitus.